PARISI, GIUSEPPE FABIO
 Distribuzione geografica
Continente #
NA - Nord America 1.425
EU - Europa 648
AS - Asia 389
AF - Africa 109
SA - Sud America 18
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.592
Nazione #
US - Stati Uniti d'America 1.402
IT - Italia 244
SG - Singapore 223
IE - Irlanda 190
CN - Cina 135
CI - Costa d'Avorio 72
DE - Germania 65
UA - Ucraina 48
RU - Federazione Russa 42
SN - Senegal 23
CA - Canada 22
NG - Nigeria 14
CZ - Repubblica Ceca 13
GB - Regno Unito 11
BR - Brasile 10
NL - Olanda 10
CH - Svizzera 7
FR - Francia 7
HK - Hong Kong 7
IN - India 7
VN - Vietnam 6
PE - Perù 5
GR - Grecia 3
JP - Giappone 3
AT - Austria 2
AU - Australia 2
FI - Finlandia 2
SE - Svezia 2
TH - Thailandia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CL - Cile 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ES - Italia 1
EU - Europa 1
IQ - Iraq 1
KR - Corea 1
LB - Libano 1
PL - Polonia 1
Totale 2.592
Città #
Santa Clara 455
Dublin 190
Chandler 179
Singapore 174
Chicago 102
Abidjan 72
Ashburn 70
Boardman 67
Civitanova Marche 65
Cambridge 50
Jacksonville 50
Lawrence 50
Andover 38
Catania 30
Nanjing 28
Bremen 26
Des Moines 24
Dakar 23
Saint Petersburg 17
Toronto 17
Milan 15
Abuja 14
Wilmington 14
Brno 13
Los Angeles 12
Washington 11
Nanchang 9
Rome 8
Beijing 6
Frankfurt am Main 6
Hong Kong 6
Redwood City 6
Shenyang 6
Amsterdam 5
Arequipa 5
Genoa 5
Hebei 5
San Francisco 5
San Mateo 5
Tianjin 5
Bernareggio 4
Changsha 4
Dong Ket 4
Pune 4
Turin 4
Bari 3
Council Bluffs 3
Falls Church 3
Favara 3
Guangzhou 3
Jiaxing 3
Messina 3
Misterbianco 3
Naples 3
Ottawa 3
Reggio Emilia 3
Seattle 3
Tokyo 3
Ansbach 2
Bangkok 2
Basel 2
Birmingham 2
Brescia 2
Cagliari 2
Costa di Rovigo 2
Enna 2
Esslingen am Neckar 2
Gravina di Catania 2
Hanoi 2
Lappeenranta 2
Moscow 2
Nardò 2
Ningbo 2
Nuremberg 2
Prineville 2
Redmond 2
Shanghai 2
Sorbo San Basile 2
Tortona 2
Baghdad 1
Bergamo 1
Brooklyn 1
Busan 1
Cesa 1
Chenzhou 1
Clifton 1
Coquitlam 1
Cosenza 1
Delhi 1
Den Haag 1
Dourados 1
Edinburgh 1
Ergolding 1
Federal 1
Floridia 1
Fort Worth 1
Frankfurt Am Main 1
Genova 1
Grafing 1
Guayaquil 1
Totale 2.010
Nome #
General anesthesia, conscious sedation, or nothing: Decision-making by children during painful procedures 75
YKL-40 as marker of severe lung disease in cystic fibrosis patients. 68
Serum YKL-40 in children with asthma 61
SAFETY AND EFFICACY OF SUBLINGUAL SPECIFIC IMMUNOTHERAPY TO HOUSE DUST MITE USING A DIFFERENT DOSAGE: A PILOT STUDY. 60
Exhaled breath temperature in astmatic children 57
HMGB1 as a new biomarker of celiac disease in children: a multicenter study 57
Lactoferrin: Cytokine modulation and application in clinical practice 57
HMGB1 values and response to HBV vaccine in children with celiac disease 56
Pilot study shows right ventricular diastolic function impairment in young children with obstructive respiratory disease 56
Lung clearance index: A new measure of late lung complications of cancer therapy in children 56
Minor pulmonary malformations in a child 55
Exhaled markers of antioxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease 55
Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review 54
Focus on pleiotropic role of HMGB1 in the onset of allergic and non- allergic respiratory diseases 53
Hypertransaminasemia in children is not always as simple as it seems 53
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review 52
Liver disease in Cystic Fibrosis: an update 51
Novel therapeutic targets for allergic airway disease in children 51
Cetirizine use in childhood: An update of a friendly 30-year drug 51
Severe Kawasaki disease in a 3-month-old patient: a case report. 50
Nutraceuticals in the prevention of viral infections, including covid-19, among the pediatric population: A review of the literature 49
Lung clearance index evaluation in detecting nocturnal hypoxemia in cystic fibrosis patients: Toward a new diagnostic tool 48
High mobility Group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate - severe asthma 47
Biomarkers in pediatric lung diseases including cystic fibrosis 47
Proposal for a new therapeutic high dosage of Pidotimod in children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome: A randomized controlled study 47
Genetic disorders of surfactant deficiency and neonatal lung disease 47
Focus on gastroesophageal reflux disease in patients with cystic fibrosis 47
Gastroesophageal reflux and respiratory diseases: Does a real link exist? 47
Cystic Fibrosis: Fighting Together Against Coronavirus Infection 46
Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our Centre 45
Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective study 45
Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility 45
Antihistamines in children and adolescents: A practical update 45
Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: A pilot study 45
The Role of Ultrasound in the Diagnosis of Pulmonary Infection Caused by Intracellular, Fungal Pathogens and Mycobacteria: A Systematic Review 44
Severe disease in Cystic Fibrosis and fecal calprotectin levels 43
Lung clearance index for evaluation of late complications of cancer therapy in children 43
Nasal Nitric Oxide and Nasal Cytology as Predictive Markers of Short-Term Sublingual Allergen-Specific Immunotherapy Efficacy in Children with Allergic Rhinitis 43
Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: A pilot study on short-term efficacy 42
Antihistamines: ABC for the pediatricians 42
Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients 41
Monoclonal antibodies in treating food allergy: A new therapeutic horizon 41
Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype 39
The immunomodulatory role of vitamin D in respiratory diseases 39
Small airways in children with allergic rhinoconjunctivitis: The potential role of a multicomponent nutraceutical 37
Nonresponse to intramuscular vaccination: An unmet need in hepatitis B vaccination 37
Leukotriene receptor antagonist drugs: A tool to face chronic urticaria in children? 36
Long-term effects of bronchopulmonary dysplasia on lung function: a pilot study in preschool children’s cohort 35
Type 2 inflammation in cystic fibrosis: New insights 35
Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria 34
Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis 34
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives 33
Respiratory symptoms in a child with IgE-non-dependent hypersensitivity to wheat 29
Upper and lower airways diseases in childhood 26
Lower airway microbiota 25
LUNG CLEARANCE INDEX: a new biomarker of ventilation inhomogeneity in pediatric respiratory diseases. 22
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-Pandemic 14
Pidotimod in allergic diseases 13
Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study 10
Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter study 9
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review 7
Cystic Fibrosis and Oxidative Stress: The Role of CFTR 7
Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease 7
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial 7
Interstitial Lung Disease in Children: “Specific Conditions of Undefined Etiology” Becoming Clearer 7
Fungi and non-tuberculous mycobacteria: emerging pathogens in cystic fibrosis 6
Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population 6
Efficacy and perceived satisfaction of 3-year SLIT in children with allergic rhinitis and asthma: a pilot study 6
Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series 5
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease 5
Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis 5
Protracted bacterial bronchitis: more to know 5
Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study 5
Foreign Body Aspiration in Children: Retrospective Case Series and Literature Update 5
Nasal microbiome in chronic rhinosinusitis 4
Sleep Respiratory Disorders in Children and Adolescents with Cystic Fibrosis and Primary Ciliary Dyskinesia 4
Totale 2.715
Categoria #
all - tutte 12.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202031 0 0 0 0 0 0 0 4 7 3 12 5
2020/2021154 0 5 20 12 39 20 18 2 6 15 10 7
2021/2022295 17 42 1 3 43 2 39 10 26 3 7 102
2022/2023656 50 12 36 42 55 109 4 120 160 6 35 27
2023/2024394 15 39 30 25 26 114 3 31 0 1 67 43
2024/20251.054 47 188 68 112 292 296 45 6 0 0 0 0
Totale 2.715